MedTrace Logo

PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study

NCT01997112 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-10-02

No results posted yet for this study

Summary

The purpose of this study is to examine if chronic paracetamol dosing increases blood pressure in patients with known high blood pressure.

Conditions

  • Blood Pressure

Interventions

DRUG

Paracetamol

DRUG

Placebo oral capsule

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • University of Edinburgh

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-06-04
Completion
2019-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01997112 on ClinicalTrials.gov